Loading clinical trials...

Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer | Clinical Trials | Clareo Health

COMPLETEDNCT01551251

Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer

The purpose of this study is to investigate the effects of tumor associated macrophage (TAM) in advanced non-small cell lung cancer (NSCLC) patients on the treatment response and outcome of these subj...

Lead sponsor: Chang Gung Memorial Hospital•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib

NCT00602433 · Advanced Nonsmall Cell Lung Cancer

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 28, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment107

Start dateJan 2006

Last updatedJul 28, 2015

Condition

Advanced Nonsmall Cell Lung Cancer

Locations shown

Chang Gung Memorial Hospital

Taipei, Taipei

Sant Paul Hospital

Taoyuan District

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 28, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions